NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=176830&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176826&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=176831&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Blueport Acquisition Ltd Prices $50 Million Initial Public Offering GlobeNewswire November 11, 2025 NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — Blueport Acquisition Ltd, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing of its initial public offering (“IPO”) of 5,000,000 units at an offering

Collaboration integrates advanced blood-based biomarkers to accelerate diagnostics and therapies for brain disorders Cohen Veterans Bioscience, Inc. (CVB), a non-profit 501(c)(3) biomedical research and technology organization and Siemens Healthineers AG (SMMNY), a global leader in medical technology, today announced a landmark collaboration to enhance the national Normative Neuroimaging Library (NNL) with advanced blood-based biomarker data.

In the news release, Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment, issued Nov. 11, 2025 by Heng Ren Partners over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Independent Sinovac Shareholders Express Strong Support for Immediate

American Binary, a U.S. technology company pioneering post-quantum cryptography (PQC) and network security, today announced the appointment of Bruce Schneier and Brian LaMacchia to its Advisory Board. https://mma.prnewswire.com/media/2820286/Bruce_Schneier_and_Brian_LaMacchia.jpg Bruce Schneieris an internationally renowned cryptographer, cybersecurity expert, and New York Times bestselling author of over a dozen books on security and privacy, including Applied Cryptography and

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=176825&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Conference Call Scheduled for Tuesday, November 18, 2025 at 11:00 am Eastern Time / 4:00 pm UK Time – Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA) (the “Company”) today announced that its third quarter 2025 financial results will be released prior to market open on Tuesday, November 18, 2025. The Company will also host

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=176819&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com